eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′ UTR

被引:152
作者
Culjkovic, B
Topisirovic, I
Skrabanek, L
Ruiz-Gutierrez, M
Borden, KLB [1 ]
机构
[1] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada
[2] CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA
[3] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA
关键词
D O I
10.1083/jcb.200501019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The eukaryotic translation initiation factor eIF4E is a critical modulator of cellular growth with functions in the nucleus and cytoplasm. In the cytoplasm, recognition of the 5' m(7)G cap moiety on all mRNAs is sufficient for their functional interaction with eIF4E. In contrast, we have shown that in the nucleus eIF4E associates and promotes the nuclear export of cyclin D1, but not GAPDH or actin mRNAs. We determined that the basis of this discriminatory interaction is an similar to 100-nt sequence in the 3' untranslated region (UTR) of cyclin D1 mRNA, we refer to as an eIF4E sensitivity element (4E-SE). We found that cyclin D1 mRNA is enriched at eIF4E nuclear bodies, suggesting these are functional sites for organization of specific ribonucleoproteins. The 4E-SE is required for eIF4E to efficiently transform cells, thereby linking recognition of this element to eIF4E mediated oncogenic transformation. Our studies demonstrate previously uncharacterized fundamental differences in eIF4E-mRNA recognition between the nuclear and cytoplasmic compartments and further a novel level of regulation of cellular proliferation.
引用
收藏
页码:245 / 256
页数:12
相关论文
共 34 条
  • [1] Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
    Boisvert, FM
    Hendzel, MJ
    Bazett-Jones, DP
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (02) : 283 - 292
  • [2] THE SOLUTION STRUCTURE OF THE RING FINGER DOMAIN FROM THE ACUTE PROMYELOCYTIC LEUKEMIA PROTO-ONCOPROTEIN PML
    BORDEN, KLB
    BODDY, MN
    LALLY, J
    OREILLY, NJ
    MARTIN, S
    HOWE, K
    SOLOMON, E
    FREEMONT, PS
    [J]. EMBO JOURNAL, 1995, 14 (07) : 1532 - 1541
  • [3] PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
    Cohen, N
    Sharma, M
    Kentsis, A
    Perez, JM
    Strudwick, S
    Borden, KLB
    [J]. EMBO JOURNAL, 2001, 20 (16) : 4547 - 4559
  • [4] A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5′ cap-binding protein, eIF4E
    Dostie, J
    Ferraiuolo, M
    Pause, A
    Adam, SA
    Sonenberg, N
    [J]. EMBO JOURNAL, 2000, 19 (12) : 3142 - 3156
  • [5] eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
    Gingras, AC
    Raught, B
    Sonenberg, N
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 913 - 963
  • [6] Coupled transcription and translation within nuclei of mammalian cells
    Iborra, FJ
    Jackson, DA
    Cook, PR
    [J]. SCIENCE, 2001, 293 (5532) : 1139 - 1142
  • [7] Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20
    Ishigaki, Y
    Li, XJ
    Serin, G
    Maquat, LE
    [J]. CELL, 2001, 106 (05) : 607 - 617
  • [8] A CAP-BINDING PROTEIN COMPLEX MEDIATING U SNRNA EXPORT
    IZAURRALDE, E
    LEWIS, J
    GAMBERI, C
    JARMOLOWSKI, A
    MCGUIGAN, C
    MATTAJ, IW
    [J]. NATURE, 1995, 376 (6542) : 709 - 712
  • [9] Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
    Kentsis, A
    Topisirovic, I
    Culjkovic, B
    Shao, L
    Borden, KLB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (52) : 18105 - 18110
  • [10] The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E
    Kentsis, A
    Dwyer, EC
    Perez, JM
    Sharma, M
    Chen, A
    Pan, ZQ
    Borden, KLB
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 312 (04) : 609 - 623